Jazz Pharmaceuticals Announces Third Quarter 2022 Financial Results and Raises Total Revenue Guidance Mid-point
Go back to Jazz Pharmaceuticals Announces Third Quarter 2022 Financial Results and Raises Total Revenue Guidance Mid-point| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 230.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $230.25 | 52 Week High | $160.00 | |||
| Open | $230.25 | 52 Week Low | $95.80 | |||
| Day High | $230.25 | P/E | 42.80 | |||
| Day Low | $230.25 | EPS | $5.38 | |||
| Volume | 1 | |||||
